On 6th February, RenalytixAI hosted a well-attended seminar on kidney disease in New York. The seminar brought together a formidable group of speakers and attendees representing the clinical and commercial ecosystem in chronic kidney disease (CKD), specifically in relation to current trends in diagnostics and the potential for multivariate, Artificial Intelligence (AI) enabled solutions such as RenalytixAI’s KidneyIntelX™. The seminar further strengthened our confidence in RenalytixAI’s investme ....
08 Feb 2019
Feedback from successful kidney disease seminar in New York
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Feedback from successful kidney disease seminar in New York
Renalytix Plc (RENX:LON) | 33.5 0 0.0% | Mkt Cap: 33.5m
- Published:
08 Feb 2019 -
Author:
Dr Jens Lindqvist -
Pages:
3
On 6th February, RenalytixAI hosted a well-attended seminar on kidney disease in New York. The seminar brought together a formidable group of speakers and attendees representing the clinical and commercial ecosystem in chronic kidney disease (CKD), specifically in relation to current trends in diagnostics and the potential for multivariate, Artificial Intelligence (AI) enabled solutions such as RenalytixAI’s KidneyIntelX™. The seminar further strengthened our confidence in RenalytixAI’s investme ....